Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study

James S. McCarthy, Julie Lotharius, Thomas Rückle, Stephan Chalon, Margaret A. Phillips, Suzanne Elliott, Silvana Sekuloski, Paul Griffin, Caroline L. Ng, David A. Fidock, Louise Marquart, Noelle S. Williams, Nathalie Gobeau, Lidiya Bebrevska, Maria Rosario, Kennan Marsh, Jörg J. Möhrle

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Fingerprint Dive into the research topics of 'Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study'. Together they form a unique fingerprint.

Medicine & Life Sciences